7.1.2021 – Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines Agency (EMA) [...]
21.12.2020 – Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the [...]
8.10.2020 -Today, the European Commission approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Once the vaccine has proven to be safe and effective against COVID-19, the contract allows Member States to purchase vaccines for 200 million people. They will also have the [...]
18.9.2020 – Today, a second contract with a pharmaceutical company entered into force following the contract’s formal signature between Sanofi-GSK and the Commission. The contract will allow all EU Member States to purchase up to 300 million doses of the Sanofi-GSK vaccine. Moreover, Member States may donate reserved doses to lower- and middle-income countries. Sanofi [...]
17.9.2020 – The EPP Group supports the use of €12 billion to help Europe’s cultural and creative sectors recover from the COVID-19 crisis. This money should be taken from the EU’s planned Recovery and Resilience Facility. “We call for clearly dedicated money to secure the jobs of almost 8 million artists and workers of the [...]
27.8.2020 – Today, the first contract the European Commission has negotiated on behalf of the EU Member States with a pharmaceutical company entered into force following the formal signature between AstraZeneca and the Commission. The contract will allow the purchase of a vaccine against COVID-19 for all the Member States of the EU as well [...]
25.8.2020 – The European Commission has today concluded exploratory talks with Moderna to purchase a potential vaccine against COVID-19. Moderna is the fifth company with which the Commission has concluded talks, following Sanofi-GSK on 31 July, Johnson & Johnson on 13 August, CureVac on 18 August, in addition to the signature of an Advance Purchase [...]
29.7.2020 – Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will [...]
24.7.2020 – The Civil Solidarity Prize will reward up to 29 not-for-profit initiatives carried out by natural persons, civil society organisations or private companies which aim to tackle the Covid-19 crisis and its manifold consequences. The overall aim of the prize, which is awarded as a one-off edition instead of the annual EESC Civil Society [...]
30.6.2020 – The European Commission has approved under EU State aid rules a €200 million Slovenian scheme to compensate large companies for the damages suffered due to the coronavirus outbreak and the confinement measures that the Slovenian Government had to implement to limit the spread of the virus. Under the scheme, companies will be entitled [...]
30.6.2020 – The European Commission has approved under EU State aid rules a €200 million Slovenian scheme to compensate large companies for the damages suffered due to the coronavirus outbreak and the confinement measures that the Slovenian Government had to implement to limit the spread of the virus. Under the scheme, companies will be entitled [...]
17.6.2020 – Member States, with the support of the Commission, have agreed on a set of technical specifications to ensure a safe exchange of information between national contact tracing apps based on a decentralised architecture. This concerns the vast majority of tracing apps that were already – or are about to be – launched in [...]
27.5.2020 – On 26 May, Commission President Ursula von der Leyen, Council President Charles Michel and the Prime Minister of Japan Shinzō Abe will hold a virtual leaders’ meeting to address matters related to the coronavirus pandemic, preparations for the upcoming G7 summit, and the implementation of the EU-Japan Strategic Partnership. As G7, G20 and [...]
18.5.2020 – The Commission has recently published the reports on implementation of the Victims’ Rights Directive and the Directive on European Protection Order. These two reports assess and analyse the national measures implementing the Directives. Under the Victims’ Rights Directive, victims of crime have rights to protection, support and access to justice. The Directive on the European [...]
28.2.2020 – The Commission is supporting Member States as they deal with the impact of the coronavirus on the tourism sector. At a videoconference yesterday, EU Ministers discussed the implications of the coronavirus outbreak on the tourism industry, mitigating measures and the recovery strategy for the tourism ecosystem, which is one of the most damaged [...]